Related Experiment Video
Updated: Jan 22, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Systematic Pathway Screening via Integrated Machine Learning Identifies FOXO-Mediated Transcription Signature for
Shuqi Wu1, Chenxi Deng1,2, Chaofan Fan3
1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China, fimmu.com.
A new machine learning model, the FOXO-related signature (FRS), effectively predicts non-small cell lung cancer (NSCLC) patient response to immune checkpoint inhibitors (ICIs). This biomarker stratifies patients, identifying those likely to benefit most from immunotherapy for improved survival outcomes.
Area of Science:
- Oncology
- Immunotherapy
- Bioinformatics
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality worldwide.
- Immune checkpoint inhibitors (ICIs) improve outcomes for some NSCLC patients, but biomarkers are needed for personalized treatment selection.
Purpose of the Study:
- To identify robust biomarkers for predicting immunotherapy response in NSCLC patients.
- To develop a predictive model integrating transcriptomic data and machine learning algorithms.
Main Methods:
- Transcriptomic data from 584 NSCLC patients treated with ICIs were analyzed.
- 101 machine learning algorithm combinations were applied to 12,025 pathways to identify prognostic signatures.
- The FOXO-mediated transcription pathway combined with Lasso-RSF algorithms was selected as the optimal predictor.
Main Results:
- The FOXO-related signature (FRS) stratified patients into high-risk and low-risk groups, significantly impacting progression-free survival (PFS) and overall survival (OS).
- FRS demonstrated superior predictive accuracy compared to clinical variables and existing models.
- Immunohistochemistry (IHC) and immune profiling supported FRS's biological relevance and association with immunotherapy response.
Conclusions:
- The machine learning-derived FRS is a potent predictor of immunotherapy response and survival in NSCLC.
- FRS offers a clinically translatable tool for precision oncology by integrating FOXO-mediated immune regulation insights.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
06:19Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
Related Concept Videos
Cell-mediated Immune Responses
Transcription Factors
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Tumor Immunotherapy
Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...